Stopped: Due to the ongoing conflict in the Tigray region
In this cohort study, the investigators will study the asymptomatic period preceding the onset of active Visceral Leishmaniasis (VL) in HIV-infected individuals from VL endemic regions in Ethiopia as an avenue to develop an evidence-based screen and treat strategy to prevent progression to active VL.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Prevalence of asymptomatic Leishmania infection
Timeframe: January 2018
Incidence rate of asymptomatic Leishmania infection
Timeframe: January 2020
Evolution of Leishmania infection markers
Timeframe: January 2020
Incidence rate of active VL
Timeframe: January 2020
Risk factors for active VL
Timeframe: January 2020
Prognostic tool for active VL
Timeframe: January 2021